BSX - Boston Scientific Corporation Stock Trading

Boston Scientific Announces Results For Third Quarter 2021 PR Newswire MARLBOROUGH, Mass. , Oct. 27, 2021 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $2.932 billion during the third quarter of 2021, growing 10.3 percen...

With the continuing spread of the COVID-19 Delta variant, the healthcare industry is continuing to enjoy investors’ attention. The industry is also expected to keep growing on the rising need for treatments for several chronic diseases. Therefore, we think it could be wise to bet on qu...

Because the rescheduling of elective surgeries and the integration of advanced technologies are driving the medical devices industry’s recovery this year, we think it could be wise to scoop up the shares of quality medical device stocks Stryker (SYK), Edwards Lifesciences (EW), Boston ...